Lectus Therapeutics' Unattributed Round

Lectus Therapeutics raised a round of funding on September 05, 2007. Investors include Wellcome Trust.

Lectus Therapeutics is a UK biopharmaceutical company with a proprietary functional proteomics screening platform (LEPTICS), enabling the discovery and development of novel, small molecule modulators …

Articles about Lectus Therapeutics' Unattributed Round: